Study shows strong link between depression and inflammation in obese patients before and after bariatric surgery

Research funded by the National Institute for Health and Care Research (NIHR) has shown that higher levels of inflammation in the blood of patients with obesity undergoing bariatric surgery predicts poorer weight loss six months after the procedure.

FDA approves the first Tysabri biosimilar for MS and Crohn’s disease – Pharmaceutical Technology

Tysabri is an anti-α4 integrin monoclonal antibody disease-modifying therapy (DMT), which was first approved by the FDA in 2004. Image Credit: JHVEPhoto / Shutterstock. The

August 25, 2023

Neurons involved in creating negative emotional states and chronic stress identified

Researchers at Karolinska Institutet in Sweden have identified a group of nerve cells in the mouse brain that are involved in creating negative emotional states

June 22, 2023

Clinical Challenges: Integrating Diet Into Crohn’s Disease Management

Incorporating diet into Crohn’s disease (CD) treatment regimens has some support, with a shift toward a whole-foods nutrition approach for symptom relief and healing. Although

December 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.